| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.006 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.007 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.008 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.008 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |